1. |
Hirota T, Tanaka T, Takesue H, Ieiri I., Epigenetic regulation of drug transporter expression in human tissues., Expert Opin Drug Metab Toxicol., 13(1):19-30., 2017.01. |
2. |
家入 一郎, Drug-drug interactions that interfere with statin metabolism., Expert Opin Drug Metab Toxicol., 2015.11. |
3. |
家入 一郎, Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions., Pharmacogenomics, 2014.01. |
4. |
家入 一郎, Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs, Drug Metab Pharmacokinet, 2013.01. |
5. |
ICHIRO IEIRI, Y. Akamine, Psychotropic drug-drug interactions involving P-glycoprotein., CNS Drugs, 2012.11. |
6. |
Ichiro Ieiri, Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2)., Drug Metab Pharmacokinet. 2012;27(1):85-105, 2012.03. |
7. |
Ieiri I, Higuchi S, Sugiyama Y, Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs., Expert Opin Drug Metab Toxicol., 5(7):703-29. , 2009.06. |
8. |
Takane H, Shikata E, Otsubo K, Higuchi S, Ieiri I., Polymorphism in human organic cation transporters and metformin action., Pharmacogenomics, 9(4):415-22., 2008.04. |
9. |
Hirota T, Takane H, Higuchi S, Ieiri I., Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms., Curr Drug Metab., 9(1):34-8., 2008.01. |
10. |
Ieiri I, Takane H, Hirota T, Otsubo K, Higuchi S., Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy., Expert Opin Drug Metab Toxicol, 2(5):651-74., 2006.10. |
11. |
Ieiri I., Takane H. and Otsubo K., The MDR1 (ABCB1) gene polymorphism and its clinical implications., Clin Pharmacokinet, 43;553-576., 2004.01. |
12. |
Takane H., Ieiri I. and Otsubo K., Genetic polymorphisms of organic anion and cation transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy., Current Pharmacogenomics, 1;245-257., 2003.01. |